CASE OF ACQUIRED COAGULOPATHY
In recent years, the number of patients receiving anticoagulant therapy worldwide is growing rapidly. This is due to the rapidly expanding scope of their application: an increasing number of patients with non-valvular heart disease, including atrial fibrillation, the risk of thromboembolic events, a...
Main Authors: | M. T. Vatutin, E. S. Gasendich, E. I. Iofe |
---|---|
Format: | Article |
Language: | Russian |
Published: |
SINAPS LLC
2018-12-01
|
Series: | Архивъ внутренней медицины |
Subjects: | |
Online Access: | https://www.medarhive.ru/jour/article/view/859 |
Similar Items
-
Acquired hemorrhagic coagulopathy due to contact with the rodenticide brodifacoum in the Nutcracker bait
by: V V Voĭtsekhovskiĭ, et al.
Published: (2012-07-01) -
Epistaxis With Warfarin Coagulopathy: An Adult Simulation Case for Residents
by: Jonathon Deibel
Published: (2020-06-01) -
Acquired Coagulopathy With Immune Checkpoint Inhibitors: An Underrecognized Association Between Inflammation and Coagulation
by: Jacinth J. Joseph, MD, et al.
Published: (2020-09-01) -
Medication-Induced Factor V Inhibition in the Setting of Refractory Coagulopathy
by: Brandon Travis Wiggins, et al.
Published: (2022-09-01) -
Acquired Coagulopathies: Current Approaches to Differential Diagnosis and Intensive Care in the Context of Evidence-Based Medicine
by: S. V. Sinkov, et al.
Published: (2007-12-01)